Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | RORC | P51449 | 6/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.51 |
| ▸ | ESRRA | P11474 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | CASP3 | P42574 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.50 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.50 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6819492 | 0.90 | ALDH1A1 (0.62) | CA1CA2CA9SMN1; SMN2MAPT | |
| SCHEMBL11642217 | 0.85 | MEN1 (0.54) | CA1CA2CA9RORCSMN1; SMN2 | |
| SCHEMBL3461025 | 0.85 | KMT2A (0.65) | SMN1; SMN2MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL3791892 | 0.85 | ALDH1A1 (0.60) | RORCSMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL4548035 | 0.84 | EPHX1 (0.70) | CA2CA9RORCSMN1; SMN2MAPT | |
| SCHEMBL10201340 | 0.83 | CA1 (0.57) | CA1CA2CA9SMN1; SMN2MAPT | |
| SCHEMBL6811020 | 0.83 | ALDH1A1 (0.54) | CA1CA2CA9MAPTMEN1 | |
| SCHEMBL7161458 | 0.83 | GAA (0.58) | SMN1; SMN2MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL29822237 | 0.82 | KDM4E (0.66) | CA1CA2CA9SMN1; SMN2ALDH1A1 | |
| SCHEMBL4311940 | 0.82 | KDM4E (0.66) | CA1CA2CA9SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101891632-B | Preparation method of 2-chloro-5-nitro-1, 4-p-phenylenediamine | OKEANOS TECH CO LTD | 2012-04-25 | — | — | CN | disclosed |
| CN-101891632-A | Preparation method of 2-chlorine-5-nitro-1,4-p-phenylenediamine | OKEANOS TECH CO LTD | 2010-11-24 | — | — | CN | disclosed |
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
| US-3973900-A | AMINO NITRO BENZENES | WELLA AG (DT) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | CA1 3273/4885CA2 1992/4885CA9 816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.